| Authors: |
Papadopoli D; Lady Davis Institute, SMBD JGH, McGill University, Montréal, Canada.; Gerald Bronfman Department of Oncology, McGill University, Montréal, Canada., Palia R; Lady Davis Institute, SMBD JGH, McGill University, Montréal, Canada.; Department of Experimental Medicine, McGill University, Montréal, Canada., Jovanovic P; Lady Davis Institute, SMBD JGH, McGill University, Montréal, Canada.; Department of Experimental Medicine, McGill University, Montréal, Canada., Tabariès S; Rosalind and Morris Goodman Cancer Institute, McGill University, Montréal, Canada., Ciccolini E; Lady Davis Institute, SMBD JGH, McGill University, Montréal, Canada.; Department of Experimental Medicine, McGill University, Montréal, Canada., Sabourin V; Lady Davis Institute, SMBD JGH, McGill University, Montréal, Canada., Igelmann S; VIB Center for Cancer Biology, Department of Oncology, KU Leuven and Leuven Cancer Institute (LKI), Leuven, Belgium., McLaughlan S; Department of Biochemistry, McGill University, Montréal, Canada., Zhan L; Department of Biochemistry, McGill University, Montréal, Canada., Kim H; Department of Experimental Medicine, McGill University, Montréal, Canada., Chekkal N; Department of Biochemistry, McGill University, Montréal, Canada., Szkop KJ; Department of Oncology-Pathology, Science for Life Laboratory, Karolinska Institute, Stockholm, Sweden., Bertomeu T; Institute for Research in Immunology and Cancer, Université de Montréal, Montréal, Canada., Zeng J; Lady Davis Institute, SMBD JGH, McGill University, Montréal, Canada., Vassalakis J; Department of Biomedical and Molecular Sciences, Queen's University, Kingston, Canada., Afzali F; Department of Biomedical and Molecular Sciences, Queen's University, Kingston, Canada., Mzoughi S; Center of OncoGenomics and Innovative Therapeutics (COGIT), Department of Oncological Sciences, Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York, United States., Guccione E; Center of OncoGenomics and Innovative Therapeutics (COGIT), Department of Oncological Sciences, Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York, United States., Tyers M; Program in Molecular Medicine, The Hospital for Sick Children, Toronto, Canada.; Department of Molecular Genetics, University of Toronto, Toronto, Canada., Avizonis D; Rosalind and Morris Goodman Cancer Institute, McGill University, Montréal, Canada.; Metabolomics Innovation Resource, McGill University, Montréal, Canada., Larsson O; Department of Oncology-Pathology, Science for Life Laboratory, Karolinska Institute, Stockholm, Sweden., Postovit LM; Department of Biomedical and Molecular Sciences, Queen's University, Kingston, Canada., Djuranovic S; Department of Cell Biology and Physiology, Washington University School of Medicine, St. Louis, United States.; Department of Molecular Biology, Cell Biology and Biochemistry, Brown University, Providence, United States., Ursini-Siegel J; Lady Davis Institute, SMBD JGH, McGill University, Montréal, Canada.; Gerald Bronfman Department of Oncology, McGill University, Montréal, Canada.; Department of Experimental Medicine, McGill University, Montréal, Canada.; Department of Biochemistry, McGill University, Montréal, Canada., Siegel PM; Department of Experimental Medicine, McGill University, Montréal, Canada.; Rosalind and Morris Goodman Cancer Institute, McGill University, Montréal, Canada.; Department of Biochemistry, McGill University, Montréal, Canada., Pollak M; Lady Davis Institute, SMBD JGH, McGill University, Montréal, Canada.; Gerald Bronfman Department of Oncology, McGill University, Montréal, Canada.; Department of Experimental Medicine, McGill University, Montréal, Canada., Topisirovic I; Gerald Bronfman Department of Oncology, McGill University, Montréal, Canada.; Department of Experimental Medicine, McGill University, Montréal, Canada.; Department of Biochemistry, McGill University, Montréal, Canada. |
